Immunogenicity Tender, Germany - 98109242

Procurement Summary

Country : Germany

Summary : Immunogenicity

Deadline : 01 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98109242

Document Ref. No. : 131805-2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Plectonic is searching for a service provider covering multiple murine in vivo studies for T-cell engagers (focusing on anti-CD3 T-cell engagers with binding to a selection of differential tumor antigens) currently in discovery / early preclinical phase. The work packages will cover the conduction of several animal experiments typically required for characterization of T-cell engagers and biologicals to evaluate anti-tumor efficacy, pharmacokinetic parameters, generate proof-of-concept data and identify lead candidates including data-driven selection of most suitable tumor antigen combinations and indication. Reference molecules for these types of workpackes are among others blinatumomab (CD19xCD3), glofitamab (CD20xCD3), AMV564 (CD33xCD3) or solitomab (EpCAMxCD3).

Doc Title: Immunogenicity

Contract Type: services
Document Type: Contract Notice
Reference Number: PLE-24-2
Contract Type: services
Authority Type: pub-undert-cga
Doc Title: Immunogenicity
Dispatch Date: 2024-03-01
Publish Date: 2024-03-04
Submission Date: 2024-04-01

Documents

 Tender Notice